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Abstract—Cancer is a complex disease and within a cancer,
subtypes of patients with distinct behaviors often exist. The
subtypes might have been caused by different hits, such as copy
number aberrations (CNAs) and point mutations, on different
pathways/cells-of-origin in a common tissue/organ. Identifying
the subtypes with subtype-specific drivers, i.e., hits, is key to the
understanding of cancer and development of novel treatments.
Here, we report the development of an integrative method to
identify the subtypes of cancer. Specifically, we consider CNAs
and their impact on gene expressions. Based on these relations,
we propose an iterative approach that alternates between kernel
based gene expression clustering and gene signature selection. We
applied the method to datasets of the pediatric cancer medul-
loblastoma (MB). The consensus number of clusters quickly
converges to three; and for each of these three subtypes, the
signature detection also converges to a consistent set of a few
hundred highly functionally related genes.
For each of the subtypes, we correlate its signature with the set
of within-subtype recurrent CNA-affected genes for identifying
drivers. The top-ranked driver candidates are found to be
enriched with known pathways in certain subtypes of MB as well
as containing novel genes that might reveal new understandings
for other subtypes.
I. INTRODUCTION
Cancer is initiated and driven by aberrant genetic events
(also known as hits), such as copy number aberrations (CNAs).
While not all hits cause cancer, those that do are called
the drivers of cancer. Further, quite a few cancers, such as
breast cancer [1], glioblastoma [2] and medulloblastoma [3],
are confirmed to contain subtypes. The subtybes of a cancer
often demonstrate inter-subtype difference and within-subtype
homogeneity in molecular profiles (e.g., gene expressions
and CNAs) and clinical outcomes (e.g., drug responses and
survival rates). Different subtypes may have arisen because
of different mechanisms, such as the hits on different path-
ways and/or different cells-of-origin [4] within the same tis-
sue/organ. Classifying the patients of a cancer into appropriate
subtypes is the key to uncover the drivers of these mechanisms.
There is a large body of literature dedicated to the develop-
ment of supervised [5], semi-supervised [6] or unsupervised
[7] approaches for the discovery of classes within a cancer
dataset. However, there are major differences between class
discovery and cancer subtyping:
∙ The levels of data for analysis are different. In class
discovery, typically one level of data (e.g., gene expres-
sion data, copy numbers/sequencing data or clinical data)
is used, whereas in subtyping, a combination of these
datasets may need to be considered. The reason is that
the establishment of a cancer subtype requires evidences
at various levels of behaviors.
∙ The validation criteria are different. In class discovery,
breadth-first cross-dataset validation is a golden measure
to test the robustness of a method and the patterns it iden-
tifies, whereas in subtyping both depth-first consistency
validation among the various levels of information and
cross-dataset validation are important.
∙ The causal models are different. In class discovery, nor-
mally no conceptual models are built and the training and
testing datasets are assumed to be naturally occurring and
identically independent. In subtyping, since multiple-level
datasets are used, conceptual models about the relations
of these datasets are often necessary and should soundly
reflect the underlying operations of biological systems.
Particularly, one type of genetic events, CNAs, is widely found
in the cancer genomes [8] and they occur at the DNA level,
which is on the upper stream of gene expressions as dictated
by the central dogma of biology. CNAs are also found to
be positively correlated with the raw expressions of affected
genes [3]. In some cancer, such as medulloblastoma, the CNA
patterns are also found to be subtype-dependent [9]. This raises
an important question: how do CNAs affect subtyping results?
There is a possibility that the clustering of gene expressions
is merely the consequences of subtype-dependent CNA pat-
terns, instead of the result of a number differentially expressed
genes (DEGs). If this is the case, clustering by the CNA
patterns may be a more fundamental way of performing cancer
subtyping. And the DEGs thus detected may only represent
the mechanic responses of CNAs but otherwise contain lit-
tle biological functions that may help trace the tumorigenic
drivers/pathways.
If, on the other hand, clustering of gene expressions is more
dependent on the set of DEGs than on the CNA-affected genes
(which may or may not be DEGs), then it means that: (1) these
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DEGs are functional; (2) most of the CNAs are passenger
events, although there could be a small number of tumorigenic
drivers; (3) the DEGs may be caused by the tumorigenic
CNAs, or any other hits, and (4) the impact of CNAs on gene
expressions need to be removed in order to study the gene-
gene interactions.
Towards this end, we propose an integrative approach to per-
form subtyping and driver-identification based on the study of
the CNA-expression relation. This paper is organized as below.
Section II explores the ’egg-and-chicken’ relation between
CNAs and gene expressions, and how it affects the clustering-
based subtyping result. Based on these findings, Sections III
and IV discuss the gene-signature based iterative subtyping
approach and the PCA based driver identification, respectively.
In Section V, we apply the algorithm to datasets of a cancer,
medulloblastoma, and compare our findings with other meth-
ods. Section VI discusses the results of the algorithms.
II. A PRELIMINARY STUDY OF THE CNA-EXPRESSION
RELATION AND ITS IMPACT ON CLUSTERING
A total number of 75 medulloblastoma cases with matched
gene expression and copy number data (by SNP arrays)
were obtained from Taylor et al. [10] (GEO: GSE21166 and
GSE14437). Another 11 gene expressions of normal cerebel-
lum were also obtained from Cho et al [9] (GEO: GSE19399).
A kernel-based spectral clustering [11] was applied to
the top 5% genes with largest variance. Fig. 1A shows the
clustering result. Gap-statistic [12] (Fig. 1B) estimates the
most appropriate number of clusters to be 3. The copy number
landscapes by SNP arrays for these 75 samples are shown in
Fig. 3.
To study the global impact of copy numbers on affected
genes, we estimated the copy numbers of individual genes
for each of the core samples. The copy number for a gene
is estimated based on the average copy number states of
all SNP probesets falling within a certain neighborhood (≤
30kbp, say) of that gene. Fig. 1C shows the boxplot of raw
expressions (in log2 scale) with respect to their copy number
states. An analysis of variance (ANOVA) indicates that there
is very significant linear correlations (𝐹 -statistic: 336.87 and
𝑝-value < 2.2 × 10−16). Since the raw expressions represent
a superimposed effects of multiple factors, e.g., cross-binding,
functional regulation and copy number responses etc., we
subtract the gene expression values of a gene by a background
signal. This background signal is estimated based on this
gene’s average expression in the normal tissue (e.g., the normal
cerebellum). The raw signal with background subtracted is
called relative signal. By doing so, it is hoped that the cross-
binding effects would be reduced and the copy number effects
enhanced. Fig. 1D shows the boxplot of relative expressions
(in log2 scale) with respect to their copy number states. An
ANOVA reveals that there is a even more significant linear
correlation (𝐹 -statistic: 1884.8, same degree of freedom; 𝑝-
value < 2.2× 10−16).
To further study the effects of copy numbers on gene
expressions, the relative expressions are plotted w.r.t. to their
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Fig. 1. A. A dendrogram showing the spectral clustering on the core samples.
B. The gap-statistic indicates the first elbow at 3, i.e., the most appropriate
number of clusters determined to be 3. The red error bars indicate the null
intervals. The gray dashed line shown in A refers to the splitting of the
dendrogram into three clusters. C. Boxplot of global relation between raw
expressions and corresponding copy number states. D. Boxplot of relative
expressions against copy number states.
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Fig. 2. The copy number profiles of a specific example (ID:73) by SNP arrays
and this patient’s position-dependent relative expressions. In the upper panel,
red lines correspond with copy number gains and blue lines correspond with
copy number losses. In the lower panel, the dots are the relative expression
values, and the red curve is the smoothed signal.
chromosomal positions. A Nadaraya-Watson algorithm [13]
with a Gaussian kernel (with a window width of 300 points)
was used to smooth the relative expressions. Fig. 2 shows the
result. It can be seen that there is strong consistency between
the copy number states and the relative expressions in regions
with CNAs. Given such significant responses of expressions
due to CNAs, it might be reasonable to assume that most of
the affected expressions may be only mechanic responses but
otherwise not involved in the cancerous process.
Note that the copy number landscapes in Fig. 3 seem to
suggest that the copy number features are dependent on the
clusters. For example, Cluster A seems to be characterized
with Chr6 deletions while the Cluster C seem to be character-
ized with CNAs on Chr17. An immediate question is whether
the dendrogram in Fig. 1A is a consequence of the CNA
patterns in Fig. 3, rather than the cause of it. For convenience,
the former situation is denoted as 𝐻0, while the latter is
denoted as 𝐻1.
As discussed in the introduction, the answer to this question
170
??????????????????????????????????????????????????????????????????????????????????????????????
???????????
?? ?? ?? ?? ?? ?? ?? ?? ?? ? ? ?? ? ?? ?? ? ?? ?? ?? ?? ?? ?? ? ?? ?? ?? ? ?? ?? ?? ?? ? ?? ?? ?? ?? ?? ?? ?? ?? ?? ?? ?? ?? ? ?? ?? ?? ?? ? ?? ?? ?? ?? ?? ?? ?? ?? ?? ?? ?? ?? ?? ?? ?? ?? ?? ?? ?? ?? ?? ?? ?? ?? ??
????????? ????????? ?????????
Fig. 3. The copy number profiles of the 75 core samples by SNP arrays.
Red, copy number gains; blue, copy number losses.
is important because it dictates which level of data is more
fundamental for performing subtyping, and hence determine
the success or failure of a subtyping method. To answer this
question, note the smoothed signal in Fig. 2. If 𝐻0 holds,
instead of using the relative expressions (note that either raw
or relative expression will produce the same dendrogram as
Fig. 1A), the position-dependent smoothed signal of it, might
produce a similar dendrogram. Furthermore, as the smoothing
window’s width increases, say from a few points to a few
hundred points, the smoothed signal would represent more of
the CNA responses than other functional effects. As a result,
the clustering of samples would remain largely stable, i.e., the
relative positions among the samples shall remain stable as
the smoothing enhances. To test this, we devise a metric to
measure the relative position of samples.
Given 𝑁 samples, and a distance matrix 𝐷 ∈ ℝ𝑁×𝑁 ,
where 𝐷𝑖,𝑗 denotes the distance between samples 𝑖 and 𝑗.
Suppose we vary the smoothing window width small enough
such that 𝐷𝑖,𝑗 also varies only by a small amount Δ𝑖,𝑗 in two
consecutive steps. The average change of distance from step
𝑠 to (𝑠+1), i.e., 𝐸{∣𝐷𝑖,𝑗𝑠+1 −𝐷𝑖,𝑗𝑠 ∣, ∀ 𝑖, 𝑗} ≜ 𝐸{∣Δ𝑠∣}, can be
used to indicate the degree of clustering stability. To broaden
the scope, two more metrics are devised. For simplicity, they
are denoted as:⎧⎨⎩
𝑀𝑠1 = 𝐸{∣Δ𝑠∣}
𝑀𝑠2 = 𝐸{∣𝐷𝑖,𝑗𝑠+1 −𝐷𝑖,𝑗1 ∣/𝐷𝑖,𝑗1 }
𝑀𝑠3 = 𝐸{∣𝐷𝑖,𝑗𝑠+1 −𝐷𝑖,𝑗𝑠 ∣/𝐷𝑖,𝑗𝑠 }
(1)
where 𝐷𝑖,𝑗1 refers to the between-sample distance before
smoothing. The same clustering as before was applied to
?
?
?
?
?
?
?
?
?
?
?
??
??
??
????
???????
????????????????
???????????????
? ?? ??? ??? ??? ??? ???
???
???
???
???
???
??????????????????????
??
??
??
?
? ?? ??? ??? ??? ??? ???
??????????????????????
? ?
?? ? ?? ?? ?? ?? ?? ?? ?? ?? ?? ?? ?? ?? ?? ?? ?? ?? ?? ?? ?? ?? ?? ? ?? ?? ? ? ?? ? ? ?? ?? ?? ?? ? ?? ?? ?? ?? ?? ?? ? ?? ?? ?? ?? ?? ?? ?? ?? ? ?? ?? ?? ?? ?? ?? ?? ?? ?? ?? ?? ?? ?? ?? ?? ?? ?? ?? ?? ?? ?? ?? ??
???????????
?? ?? ?? ?? ?? ?? ?? ?? ?? ?? ?? ?? ?? ?? ?? ?? ?? ?? ?? ? ? ?? ? ?? ?? ?? ?? ?? ?? ?? ???? ?? ?? ?? ?? ? ?? ? ?? ?? ?? ?? ? ?? ?? ? ? ? ?? ?? ?? ?? ?? ?? ?? ?? ?? ?? ?? ?? ?? ?? ?? ?? ?? ?? ?? ?? ?? ?? ?? ?? ?? ??
???????????
?? ?? ?? ?? ?? ?? ?? ?? ?? ?? ?? ?? ?? ?? ?? ?? ?? ?? ?? ?? ? ? ? ? ?? ?? ?? ? ?? ?? ?? ?? ? ?? ?? ?? ?? ?? ?? ?? ?? ?? ?? ?? ?? ?? ?? ?? ?? ?? ?? ?? ?? ?? ? ?? ?? ?? ?? ?? ?? ?? ? ?? ?? ?? ?? ?? ?? ?? ?? ?? ?? ? ??
???????????
Fig. 4. The clustering stability metrics as smoothing window width varies
and corresponding impact on clustering. A. 𝑀𝑠1 from 𝑠 = 2 to 𝑠 = 61, as
the window width increases by 5 in each step, from 5 to 300. B. Black, 𝑀𝑠2 ;
red, 𝑀𝑠3 . C-E. The dendrograms under different smoothing parameters.
the smoothed signals. Fig. 4A-B show these metrics as the
smoothing window varies.
It can be seen that when smoothing window is close to 0
(0 indicates the un-smoothed data), there are large changes
of relative positions. But as the window width increases, its
impact on the relative position reduces significantly. This is
confirmed by the resulting dendrograms in Fig. 4C-E. Note
that a slight smoothing in Fig. 4C quickly distort the cluster
boundaries as compared with Fig. 1A. But as the smoothing
enhances, the dendrograms remain quite stable. Note that
throughout the procedure, even though the cluster boundaries
are no longer consistent with that by the un-smoothed data, the
local positions seem to remain stable. Particularly, the Cluster
A samples (red) remain close to each other even when the
smoothing is strong. So are the Cluster B samples (blue). This
means that the mechanic responses of CNAs alone have a
major impact on the clustering, and hence subtyping result.
Nevertheless, the smoothing almost completely obscures the
cluster boundaries, which means the high frequency compo-
nents of expressions might have played a more important
role in establishing the subtypes. Since a gene is regulated
by an unknown number of factors, including CNAs, and the
smoothing used here is position-dependent, impact of other
non-position-dependent regulators (e.g., point mutations) will
be eliminated. But these factors, together with some of the
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Fig. 5. The role of CNAs in cancer, subtypes and clustering of expression
data.
CNAs, are both possible drivers of cancer. Note that some
samples in Fig. 3 do not have any CNAs at all, but may
belong to separate clusters. A reasonable theory is that, the
CNAs within a sample do harbor some tumorigenic drivers,
which activate certain pathways in certain cells-of-origin [14],
and results in subtypes. And CNAs may not be the only
possible factor to activate these pathways. The samples in Fig.
3 without obvious CNAs may contain other aberrations that hit
the same pathways as other samples in the cluster. From this
study, it appears that neither 𝐻0 nor 𝐻1 is accuate to describe
the relations among CNAs, gene expressions and subtypes.
Instead, the relations are summarized in Fig. 5.
Fig. 5 indicates that gene signature, i.e., subtype-specific
DEGs might be more directly related to the subtype mecha-
nisms. And gene signature is more important in determining
the class boundaries, whereas CNA-induced responses may
only affect the localized relation of a sample, i.e., what is in
the neighborhood of a sample. Therefore, performing cancer
subtyping by signature selection may be closer to unveil the
common mechanism for a subtype. The next section elaborates
on a gene signature based subtyping algorithm.
III. THE SUBTYPING ALGORITHM
As described above, gene expression signature underpins
the biological processes, and is usually enriched with known
canonical pathways, which may help improve the interpretabil-
ity of each subtype. We therefore propose to integrate signature
detection into the subtyping process. A general framework is
proposed as below:
I. Given an expression dataset 𝑋 = {𝑋𝑖,𝑗 ∣𝑖 = 1..𝑁, 𝑗 =
1..𝐽} with 𝑁 samples and 𝐽 genes, divide 𝑋 into two
mutually-exclusive and equally-sized datasets, 𝑋1 and
𝑋2, such that 𝑋=[𝑋1 𝑋2].
II. Perform clustering on 𝑋1 and determine the number
(say, 𝐾) of clusters in 𝑋1, dividing the samples into
𝐾 subgroups.
III. Use the trained class labels of 𝑋1 by Step II to predict
the class label for each sample in 𝑋2.
IV. Detect subtype gene signature Φ𝑘 for subtype 𝑘 of 𝑋2
based on the predicted class labels in Step III.
V. Let Φ = Φ1 ∪ Φ2... ∪ Φ𝐾 . Update 𝑋2 with ?ˆ?2, where
each row in ?ˆ?2 corresponds to a signature gene in Φ.
VI. Perform Step II on ?ˆ?2 and use the training results to
obtain a updated ?ˆ?1 and updated signature Φ.
VII. Repeat Steps II to VI, till certain convergence criterion,
(e.g. stability of the signature genes) is reached.
The above framework assumes that there are no noisy and/or
outlier samples in the dataset, which may not be true. Noisy
and/or outlier samples tend to have huge impacts on the
clustering results. A strategy to handle this problem is to detect
such samples and retain them from the training samples.
Besides outliers, other issues including the clustering, sig-
nature detection, training, testing and convergence shall be
discussed in the follows.
A. Outlier Detection
Most clustering algorithms are extremely sensitive to out-
liers, which may lie in-between clusters or lie beyond all
clusters. Here, the outliers are identified in two steps. First, a
one-class outlier detection is performed using the Mahalanobis
distance method [15]. This step efficiently removes samples
that are far from any clusters. These samples might have
been incorrectly diagnosed or labeled. Second, samples that
lie in-between clusters are detected by consensus clustering
[16]. This category of outliers might have been due to noisy
measurements but not mis-labeling.
In the first step, a sample that has large Mahalanobis
distance tends to be an outlier and its squared value can be
approximated by a 𝜒2𝑝 distribution, where 𝑝 is the dimension
of the data. A major challenge here is that there tend to be
more genes than samples, making the covariance matrix rank-
deficient and hard to determine. To handle this, usually a
singular value decomposition (SVD) is performed and only
the first few principal components are selected. In the second
step, in-between cluster outliers are prone to misclassification
after repetitive re-sampling. This can be easily spotted by the
consensus clustering method. Outliers detected by both meth-
ods are retained for subsequent validation and the remaining
sample are used for training the subtype patterns.
B. A Consensus Algorithm for Clustering and Determining the
Number of Clusters
There is a large body of literature in unsupervised clustering.
But two major issues in gene expression subtyping post chal-
lenge on the stability of the clustering results. First, samples
within a subtype may not be multivariate Gaussian in the gene
expression space, but may be of rather irregular geometries.
Second, the densities vary from subtype to subtype, with some
samples lying in-between clusters.
An efficient method to handle the within-cluster and
between-cluster variability by consensus clustering was pro-
posed by Monti et al. [16]. The algorithm works by checking–
under a number of clusters 𝐾 enumerating from 2 to certain
upper limit–how stable two samples are within the same cluster
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after a large number of re-samplings. The degree of how much
two samples 𝑖 and 𝑗 stay in the same cluster is measured by
the entry of a consensus matrix, ℳ(𝑖, 𝑗). Since the matrix ℳ
is similar with the distance matrix in hierarchical clustering,
a meta-algorithm to perform clustering based on ℳ is used
to determine the consensus clusters. While this algorithm has
the advantage of uncovering cluster patterns in the face of
sample variability, it also has the advantages that the number
of samples needs to pre-specified and enumerated, and that
the re-sampling scheme needs to be carefully devised.
Here, we propose a modified consensus clustering, where
the exhaustive enumeration is avoided, the re-sampling scheme
is optimized and the clustering metric is topology-based.
Specifically, given a training dataset 𝑋1 with 𝑛 samples, the
following steps are taken:
a. Perform sampling with replacement from 𝑋1 by 𝐻 times
to obtain 𝑋(1)1 , ..., 𝑋
(𝐻)
1 . As a result of this scheme, some
samples may be duplicated. For each re-sampled dataset,
𝑋
(ℎ)
1 , only the set of unique samples, denoted as ?˜?
(ℎ)
1 , is
used for clustering. However, the number of duplicates for
each sample in ?˜?(ℎ)1 is recorded for later use.
b. The spectral clustering [11] used in Section II is applied
to each dataset ?˜?(ℎ)1 . Instead of traversing from 𝐾 = 2 to
𝐾 equals a certain number, the most appropriate number
of clusters within ?˜?(ℎ)1 is determined by the gap statistic
method [12].
c. If two samples 𝑖 and 𝑗 (𝑖, 𝑗=1,...,𝑛) both appear in ?˜?(ℎ)1
and they belong to the same cluster, then the corresponding
entry of a ℎ-dependent matrix ℳ(ℎ)(𝑖, 𝑗) can be evaluated
with ℳ(ℎ)(𝑖, 𝑗) = 𝑐𝑖𝑐𝑗 . Here, 𝑐𝑖 and 𝑐𝑗 are the numbers of
repeats for each sample in ?˜?(ℎ)1 in Step a., respectively. If
𝑖 and 𝑗 are not in the same cluster, or not simultaneously
selected by re-sampling, ℳ(ℎ)(𝑖, 𝑗) = 0 .
d. The consensus matrix is evaluated as: ℳ(𝑖, 𝑗) =∑
ℎℳ(ℎ)(𝑖, 𝑗).
In the above steps, if ℳ(𝑖, 𝑗) = 0, it means 𝑖 and 𝑗
never appear to be under the same cluster. Otherwise, the
larger the value ℳ(𝑖, 𝑗), the more likely 𝑖 and 𝑗 actually
belong to the same cluster. Further, suppose the average of the
most appropriate number of clusters for all 𝐻 re-samplings is
𝐾, presumably this is also consensus number of clusters for
the original dataset 𝑋1. Hierarchical clustering can then be
performed on 1/ℳ(𝑖, 𝑗) and the resulting dendrogram is cut
with 𝐾 clusters. As a result, each sample in the training dataset
is now assigned a trained class label 𝑘 ∈ {1, ...,𝐾}.
C. Gene Signature Detection
Step III. of the framework proposes to predict the class
labels of the testing set 𝑋2 based on the trained results of 𝑋1.
To implement this step, we use the adaptive boosting (Ad-
aBoost) algorithm [17], [18], which was shown to outperform
linear classifiers (e.g., SVM) in the case of irregular sample
spaces common in biomedical data [19]. Specifically, a real
number two-class AdaBoost is used. To predict samples in
𝑋2 that are in cluster 𝑘, all samples with trained label 𝑘 in
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Fig. 6. Overview of the integrative subtyping algorithm.
𝑋1 are regarded as the {-1} class, while all other samples
(which may include non-cancer controls) in 𝑋1 are regarded
as the class {+1}. The two classes of samples are then used
in training AdaBoost. Each sample in 𝑋2 is predicted with
a real value 𝜂 ∈ (−1,+1), indicating how much likely it is
in the k cluster. The closer 𝜂 is to -1, the more likely it is
in the 𝑘 cluster. In the case a sample is predicted to be in
more than one cluster, it is further predicted to be the cluster
for which 𝜂 is smallest. This step assign a testing class label
𝑘 ∈ {1, ...,𝐾} for each sample in 𝑋2.
For each predicted cluster in 𝑋2, the SAM method [20] is
used to obtain a list of differentially-expressed genes (DEGs)
between this cluster and the normal (non-cancer) samples.
Consequently, a set of unique DEGs, or signature genes, Φ𝑘
is obtained for cluster 𝑘. A reduced dataset of 𝑋2 based on
the union of all Φ𝑘 is then used in return for the consensus
clustering training. The trained class labels are then used
to predict the class labels for samples in 𝑋1 and so on
so forth. This procedure continues till the set of signature
genes between the last two steps are stable enough, say the
percentage of change is less than 5%.
An overview of the above algorithms is shown on Fig. 6.
IV. THE SUBTYPE-SPECIFIC DRIVER
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IDENTIFICATION ALGORITHM
According to the preliminary analysis in Section II, even
within a subtype, there could be different driving events. Here,
we focus on the dominant subtype-specific events, i.e., CNAs.
CNAs often occur on a broad region in the cancer genome and
presumably harbor far more genes than necessary to trigger
cancer. As a result of the efficient responses (cf. Fig. 2)
from CNAs, most of which may be mechanic but otherwise
non-cancerous, the search for candidate CNAs that might be
responsible for the cancerous process becomes challenging (cf.
Fig. 5). Nevertheless, the subtype-specific DEGs, i.e., gene
signature, offer a retrospective clue for subtype-specific driver
identification.
A CNA-affected gene can activate the cancerous process
through its CNA-induced aberrant expressions. Therefore, its
expression may likely be correlated with the signature genes,
which are believed to be the consequences of subtype-specific
processes. To identify the drivers, for a subtype 𝑘 and its
signature 𝑆𝑘 (∣𝑆𝑘∣ ≜𝑀 ), and 𝐿 candidate CNA genes, an 𝑀 -
by-𝐿 matrix 𝑍𝑘 of pair-wise Pearson correlation coefficients
between the signature genes and the expressions of the CNA
genes is computed. We may assume that a row-wise zero-
meaned operation has been applied to 𝑍𝑘. A PCA approach
can next be applied to determine the correlation of each CNA
with the set 𝑆𝑘, as follows:
a. Perform an SVD: 𝑍𝑘 = 𝑈Σ𝑉 𝑇 , and then project 𝑍𝑘 onto
the first principle vector 𝑢1 of 𝑈 , to give 𝑧1 = 𝑢𝑇1 𝑍𝑘. The
individual entry of 𝑧1 represents the overall correlation of
each CNA gene with the set of signature genes.
b. For a candidate CNA gene 𝑙 ∈ {1, .., 𝐿}, the more positive
𝑧𝑙1 is, the more gene 𝑙 is positively correlated with 𝑆𝑘, and
vice versa. Therefore, the values of 𝑧1 provide a ranking
for the candidate CNA genes.
c. The empirical confidence interval (CI) of 𝑧𝑙1 can be ob-
tained by bootstrapping. If the CI of 𝑧𝑙1 at significance level
𝛼 does not include 0, gene 𝑙 is determined to be a significant
regulator.
The set of candidate CNA genes can be obtained by finding
the set of significantly recurrent CNAs in subtype 𝑘 via
GISTIC [21] using the SNP arrays matching to the samples
in 𝑘.
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Fig. 7. Outlier detection. A, outlier detection by the Mahalanobis distance
method in 𝒟1, and; B. in 𝒟2.
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Fig. 8. A and B. The histograms for the consensus number of clusters for
the two datasets. C and D. The converged consensus matrices in heatmaps
for the two datasets, 𝒟1 (C), and 𝒟2 (D), respectively. Red color indicates
two samples are repetitively predicted to be in the same cluster, while green
color indicates they are rarely so.
V. RESULTS AND DISCUSSION
To implement the proposed approach, we used two pub-
lished and publicly available medulloblastoma datasets. The
first dataset consists of 75 samples by Taylor’s group [10]
(GEO: GSE21166 and GSE14437). The second dataset con-
sists of 62 medulloblastoma samples from Kool et al. [3]
(GEO: GSE10327). For convenience, the two datasets are re-
ferred to as 𝒟1 and 𝒟2, respectively. Only probesets common
to both 𝒟1 and 𝒟2 are used.
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TABLE I
PATHWAY ANALYSIS FOR EACH SUBTYPE BY ITS SIGNATURE
Pathways (𝑝-value) Genes
Subtype A
NF-𝜅B Signaling
(5.89× 10−5)
TLR1, BMP4, TRD@, KRAS, IRAK1,
PIK3R3, MAP3K7, TGFA, PDGFRA,
TDP2, LTBR, TRA@, TNFRSF11B
Wnt/𝛽-catenin Signaling
(6.60× 10−5)
FZD10, PPP2R5D, WNT16, WIF1,
MAP3K7, GNAO1, CD44, FZD6,
DKK4, DKK2, LEF1, DKK1, WNT11
Subtype B
Axonal Guidance Signaling
(2.28× 10−4)
GLI2, ARHGEF7, SEMA6A, PTCH1,
PLXND1, BMP5, MICAL1, NTRK2,
NTRK3, CXCL12, NGFR, PDGFD,
GLI1, PRKD1, WNT5A, UNC5C
Hedgehog signaling
(5.57×10−3)
PTCH1, GLI1, GLI2, WNT5A,
CSNK1E, BMP5, GAS1, ATOH1
Subtype C
PPAR Signaling
(6.9× 10−4)
NR2F1, PDGFA, PDGFRA, NCOR2,
AIP
Protein Kinase A Signaling
(2.4× 10−3)
NR2F1, PDGFA, PDGFRA, NCOR2,
AIP
p53 Signaling
(3.7× 10−3)
GADD45G, C12orf5, TP53BP2, SER-
PINE2
Glucocorticoid Receptor
Signaling (8.9× 10−3)
POU2F1, TAF5, PRL, SGK1,
MAPK10, NCOR2, SMARCA4
A. Outlier Detection
Fig. 7A-B shows the result of the Mahalanobis distance
method of outlier detection. Note that at 99% confidence, only
𝒟2 is found to contain an outlier 313. One sample in 𝒟1 is
close to but never exceed the threshold. As a result, 75 and
61 samples are used for training and testing in 𝒟1 and 𝒟2,
respectively. The total number of 136 samples were further
processed by quantile normalization, to ensure that a gene has
close dynamic ranges in both datasets.
B. Subtyping
To implement the subtyping framework, we used the 𝒟1
and 𝒟2 samples as the 𝑋1 and 𝑋2 in Section III, respectively.
One hundred re-samplings (i.e., 𝐻=100) were performed for
each training step. The algorithm converges extremely fast,
both in terms of the number of clusters 𝐾 and the stability
of the gene signatures. Fig. 8 shows the histograms for the
converged consensus numbers of clusters, and expected value
of 𝐾 = 3 in both datasets; and the consensus matrices as
clustered and cut with 𝐾 = 3 clusters.
It appears from Fig. 8C and D that, although both datasets
demonstrate strong consensus in having three subtypes, the
second dataset is much less noisy than the first one.
Table I summarizes the top enriched canonical pathways for
each subtype. It is easy to see that Subtype A corresponds
to the Wnt-pathway associating subtype, Subtype B to the
Shh-pathway associating subtype, and Subtype C to the non-
Wnt/non-Shh patients, in medulloblastoma.
C. Driver Identification
Copy number measurements via SNP arrays of 𝒟1
were processed and submitted to GISTIC (via genepat-
tern.broadinstitute.org) for detection of recurrent CNAs within
each subtype. The results of this pre-selection step are listed
in Table II.
TABLE II
NUMBERS OF CANDIDATE CNAS WITHIN EACH SUBTYPE
Subtype A Subtype B Subtype C
gains losses gains losses gains losses
# genes 0 359 0 281 692 561
As described in Section IV, for each subtype, pair-wise
correlations between the pre-selected CNAs and the gene
signature were then computed and the PCA-based ranking
method was applied to determine the significance score for
each candidate regulator. Ten thousand bootstrap replications
were performed to determine the empirical confidence in-
tervals of the obtained scores. In all three subtypes, reg-
ulators with empirical 𝑝-values < 0.005 were determined
to be significantly correlated with the signature genes. The
results are summarized in Table III. Of note, Subtype A is
only marginally enriched (not significantly) with Wnt-pathway
genes, but some other highly ranked candidate genes such as
NRN1 and TULP4 seem to be interpretable. While TULP4
was proposed to be a Wnt subtype tumor suppressor by [14]
and its copy losses may cause the loss-of-function of tumor
suppressing; NRN1 was found to be among the most down-
regulated signature for a drug resistant medulloblastoma cell-
line [22]. Subtype B contains significant axonal guidance
genes, and this pathway is also represented in its signature
(Table I). Particularly, PTCH1, which is frequently deleted in
Subtype B, plays an important role in Shh-pathway signaling
by inhibiting the Smoothened. The deletions of PTCH1 might
cause the Shh pathway to be permanently turned on, which
could be cancerous if it occurred during brain development.
In Subtype C, where a large number of significant CNA drivers
are found, it is of interest to note that even though signature of
Subtype C is not enriched with Wnt genes, the CNA drivers do
seem to suggest this trend. This might shed light on the disease
mechanism of this group, which is much less understood
compared with the other two subtypes.
VI. CONCLUSION
In this work, we have conducted a thorough investigation on
the CNA-gene expression relations, based on which we formu-
lated a theory for the CNA-induced subtype-specific cancerous
process. A two-step algorithmic framework was then devel-
oped to perform gene-signature based cancer subtyping and
to identify subtype-specific CNAs drivers. The algorithm was
applied to datasets of medulloblastoma, and produced dataset-
invariant subtyping results. The driver identification results
were found to be enriched with cancer-driving pathways. This
study has contributions in several aspects.
First, the CNA-gene expression study unveils the efficient
responses of CNAs on gene expressions. Second, a subtyping
technique that avoids the effects of the mechanic responses
of CNAs by depending on the signature-based clustering is
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TABLE III
CANDIDATE CNA DRIVERS WITHIN EACH SUBTYPE AND PATHWAY ANALYSIS
Pathways (𝑝-value) Total # Candidate CNA Drivers
Subtype A 171
Wnt/𝛽-catenin Signaling (0.183) SOX4, MAP3K7, PPP2R5D
Some top-ranked non-pathway genes NRN1 (No.1), TULP4 (No. 18)
Subtype B 181
Axonal Guidance Signaling (2.04×10−3) AKT1, NTRK2, RGS3, CDK5, PRKCD, PTCH1, ABL1, NFATC1, PLXNB2, RAC3
Glioma Signaling (8.91× 10−3) IGF2, AKT1, PRKCD, ABL1
Subtype C 878
EIF2 Signaling (9.33× 10−7) RPS20, EIF3H, GRB2, RPS17/RPS17L, EIF3F, RPS2, RPL30, RPL23A, RPL23, RPS23,
RPLP0, EIF4E, EIF3M, RPS24, EIF4G2, RPL36A/hCG 1787519, EIF4A3, PAIP1, RPS15,
RPLP2, RPL8, RPL18, RPL13A, RPL13
mTOR Signaling (3.24× 10−5) RPS6KB1, RPS20, PLD2, EIF3H, DDIT4, PPP2R2A, RPS17/RPS17L, EIF3F, RPS2, RAC1,
RPS23, EIF4E, EIF3M, RPS24, RHOG, EIF4G2, RHOT1, EIF4A3, TSC2, RPS15, PRKCA
Wnt/𝛽-catenin Signaling (1.14× 10−4) TP53, SFRP4, WNT3, FRAT1, PPP2R2A, CSNK1D, WNT16, FZD1, CDH1, SOX9, NLK,
CDH5, DKK3, RARA, CD44, SFRP5, DKK4, SFRP1, FZD2
function-oriented and addresses quite a few issues in unsu-
pervised learning of cancer datasets. Third, subtype-specific
driver identification provides an efficient algorithm to relate
the dysregulated pathway activities to the aberrations at the
DNA level. Its capability to rank such candidates provides a
way to automate the process of driver identification.
We also note that there are a few limitations in current
study. For example, it is assumed that relationships between
the CNA-genes and the gene signature are time-invariant. This
limits the candidates to those already in equilibrium states and
lacks the potential to uncover those drivers that play roles
dynamically. It is also desirable that in future works, other
cancers with subtypes can be tested with the current method
for identifying cancer drivers.
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